Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02048917 · ClinicalTrials.gov registry record · Phase 1
Optimization of Smoking Cessation Strategies Concurrent With Treatment of Tobacco Related Malignancies
A Phase 1 study of Lung Cancer and Head and Neck Cancer, sponsored by University of Kentucky.
- Completed
- Registry status
- Phase 1
- Development phase
- 93
- Enrollment target
- 10
- Study locations
NCT02048917 is a Phase 1 study of Lung Cancer and Head and Neck Cancer that has completed, run by University of Kentucky. The registered enrollment target is 93 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (90% lower). The trial reports 10 study locations across 2 states.
The verdict
NCT02048917, a Phase 1 study of Lung Cancer and Head and Neck Cancer, has completed, sponsored by University of Kentucky.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 93 participants
- Enrollment target
- 10
- Study locations
Study Summary
The purpose of this study is to find an optimal smoking cessation strategy in patients undergoing therapy for lung and head and neck cancers at selected cancer centers in Kentucky by delivering high quality smoking cessation to all enrolled patients. This study will also examine the feasibility of routinely implementing an array of smoking cessation strategies for this patient population.
Conditions Studied
Interventions
- DRUG High Intensity Counseling + Long Acting NRT + PRN NRT
- DRUG High Intensity Counseling + bupropion + PRN NRT
- DRUG High Intensity Counseling + varenicline + PRN NRT
- DRUG High Intensity Counseling + Long Acting NRT
- DRUG High Intensity Counseling + bupropion
Study Locations (10)
Kentucky
- King's Daughters Medical Center - Ashland
- Hardin Memorial Health Cancer Care Center - Elizabethtown
- ARH Cancer Center - Hazard
- Kentucky Cancer Clinic - Hazard
- Lexington Veterans Affair Medical Center - Lexington
- University Of Kentucky, Markey Cancer Center - Lexington
- University of Louisville, James Graham Brown Cancer Center - Louisville
- St. Claire Regional Medical Center - Morehead
- Owensboro Health - Owensboro
West Virginia
- St. Mary's Medical Center - Huntington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2014-07-22 |
| Est. Completion | 2019-05-15 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02048917
The ClinicalTrials.gov registry entry for NCT02048917 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (90% lower). The listed sponsor is University of Kentucky, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Lung Cancer appearing as the primary indexed condition, and to 5 interventions - of which High Intensity Counseling + Long Acting NRT + PRN NRT is the first listed.
NCT02048917 reports 10 study locations spanning 2 distinct geographic areas - top geographies include Kentucky, West Virginia.
Frequently Asked Questions
What is clinical trial NCT02048917 about?
NCT02048917 is a clinical study titled "Optimization of Smoking Cessation Strategies Concurrent With Treatment of Tobacco Related Malignancies". The purpose of this study is to find an optimal smoking cessation strategy in patients undergoing therapy for lung and head and neck cancers at selected cancer centers in Kentucky by delivering high quality smoking cessation to all enrolled patients. This study will also examine the feasibility of r...
What is the current status of trial NCT02048917?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 93 participants. The study started on 2014-07-22. Estimated completion is 2019-05-15.
What conditions does trial NCT02048917 study?
This clinical trial studies the following conditions: Lung Cancer, Head and Neck Cancer.
What interventions are being tested in trial NCT02048917?
The interventions under investigation include: High Intensity Counseling + Long Acting NRT + PRN NRT (DRUG), High Intensity Counseling + bupropion + PRN NRT (DRUG), High Intensity Counseling + varenicline + PRN NRT (DRUG), High Intensity Counseling + Long Acting NRT (DRUG), High Intensity Counseling + bupropion (DRUG).
Who is sponsoring clinical trial NCT02048917?
This trial is sponsored by University of Kentucky, which has 54 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02048917 being conducted?
This trial has 10 study locations across Kentucky, West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study Investigating BG-60366 in Adults With Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer
RECRUITING · Phase 1
-
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
RECRUITING · Phase 1
-
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
RECRUITING · Phase 1
-
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
RECRUITING · Phase 1
-
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.